Group 1 - On October 22, a total of 8 companies were investigated by funds, with a focus on Meihao Medical (301363) and Yingboer (300681) [1] - Meihao Medical attracted the most attention, with 21 funds participating in the investigation, while Yingboer and Jusa Long (301131) had 9 and 3 funds respectively [1] - Among the companies investigated, 1 is from the main board and 7 are from the ChiNext board [2] Group 2 - Of the companies investigated, 5 have a total market capitalization of less than 10 billion yuan, including Jusa Long, Hualan Group (301027), and Jizhi Co. (300553) [2] - In terms of market performance, 3 stocks among the investigated companies rose in the last 5 days, with Meihao Medical, Yingboer, and Jusa Long showing increases of 2.98%, 0.67%, and 0.63% respectively [2] - Yingboer reported the highest net profit growth among the companies that have released their Q3 reports, with an increase of 191.18% year-on-year [2]
10月22日8家公司获基金调研